SCHEMBL7799751

SCHEMBL7799751

Cc1nn(C)c2nc(C(C)C)c(CO)c(-c3ccc(F)cc3)c12

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10517469 0.88 GCGR (0.45) GCGR
SCHEMBL10518455 0.86 GCGR (0.44) GCGR
SCHEMBL8021235 0.79 GCGR (0.42) GCGR
SCHEMBL8949777 0.79 GCGR (0.74) GCGR
SCHEMBL9384902 0.78 GCGR (0.47) GCGR
SCHEMBL8949822 0.78 GCGR (0.88) GCGR
SCHEMBL7791791 0.76 GCGR (0.40) GCGR
SCHEMBL2656279 0.76 GCGR (1.00) GCGR
SCHEMBL9383080 0.76 GCGR (0.53) GCGR
SCHEMBL10424217 0.75 GCGR (0.62) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0535548-B1 Inhibitor of atherosclerotic intimal thickening NISSAN CHEMICAL IND LTD (JP) 2001-11-21 EP disclosed
US-6162798-A Inhibitor of atherosclerotic intimal thickening NISSAN CHEMICAL INDUSTRIES LTD. (JP) 2000-12-19 US disclosed
EP-0339358-B1 Pyrazolopyridine type mevalonolactones NISSAN CHEMICAL IND LTD (JP) 1994-07-13 EP disclosed
EP-0535548-A1 Inhibitor of atherosclerotic intimal thickening NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1993-04-07 EP disclosed
US-5024999-A Anti-hyperlipidemia, anti-atherosclerosis agents NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-06-18 US disclosed
WO-1989010365-A1 PYRAZOLOPYRIDINE TYPE MEVALONOLACTONES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1989-11-02 WO disclosed
EP-0327500-A2 5-Substituted 1H-pyrazolo[3,4-b]pyridine derivatives, their preparation and pharmaceutical compositions containing them SANDOZ AG (CH) 1989-08-09 EP disclosed
US-4822799-A Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals SANDOZ PHARM. CORP. (US) 1989-04-18 US disclosed